<DOC>
	<DOCNO>NCT01941784</DOCNO>
	<brief_summary>This pilot clinical trial study health education intervention reduce weight gain patient newly diagnose stage I-IV breast cancer undergo chemotherapy . A health education program may reduce weight gain improve quality life patient undergo chemotherapy breast cancer .</brief_summary>
	<brief_title>Health Education Intervention Reducing Weight Gain Patients With Newly Diagnosed Stage I-IV Breast Cancer Undergoing Chemotherapy</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To determine feasibility conduct weight maintenance intervention , term recruit retain participant . II . To obtain preliminary data effectiveness intervention prevent weight gain body composition , self-efficacy , perceive stress , fatigue , depression , exercise capacity , health-related quality life ( HRQL ) . Changes physical activity dietary intake also monitor . III . To determine weight control protocol require refinement use randomize controlled trial . IV . To determine many participant opt enroll short-term healthy lifestyle program completion final testing visit . OUTLINE : Participants undergo four 30-60 minute health education session 3 follow-up phone session interventionist trained behavioral science , physical activity nutrition , positive psychology 12 month . EDUCATION SESSION I : Participants receive information interventionist concern healthy diet choice exercise begin keep food log . EDUCATION SESSION II : Interventionists review information session I patient food log . Participants receive recommendation exercise set activity goal . EDUCATION SESSION III : Participants receive information determine portion size importance strength training building lean muscle mass . EDUCATION SESSION IV : Interventionists review information previous 3 session discuss importance planning goal set participant . The interventionist also discuss physical mental barrier exercise . After completion education session , patient receive 3 phone call time convenient patient answer question information learn previous educational session . After completion study , participant follow 12 month .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Weight Gain</mesh_term>
	<criteria>Women newlydiagnosed breast cancer , stage IIV within first two round chemotherapy 3.1.2 Women receiving , schedule receive , one following class therapy adjuvant neoadjuvant setting : anthracyclines , taxanes , cyclophosphamide , trastuzumab . Participants must within first two round chemotherapy Body mass index ( BMI ) &gt; 20 Treating physician approval participate study Ability understand willingness sign Institutional Review Board ( IRB ) approve informed consent document Diagnosis recurrent breast cancer Women already participate formal medically prescribe weight management program Women already complete two round chemotherapy Women pregnant nursing</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>